3'',4''-Dihydroxyphenylacetone (Item No. 19522) is an analytical reference standard. It is a minor metabolite of 3,4-MDEA (Item Nos. 14085 | 15689), MDMA, and α-methyldopa produced by oxidative deamination. This product is intended for forensic and research applications.
3',4'-Dihydroxypropiophenone, also known as DOPA, is a metabolite of dopamine, which is produced in the brain and kidneys. DOPA is a precursor to the synthesis of melanin, which is found in skin cells. Glutamate dehydrogenase converts DOPA to 3-methoxytyramine, which can be detected chromatographically in urine samples. Examining a urine sample for DOPA testing can be used to diagnose Parkinson's disease. DOPA may also be detected in plasma in patients with bacterial and urinary tract infections
A metabolite of racemic 3,4-methylenedioxyethylamphetamine.
3',4'-Dihydroxyphenylacetone , MDMA, and α-methyldopa produced by oxidative deamination. This product is intended for forensic and research applications.
3,4-dihydroxylphenylacetaldehyde (DHPAA) synthase catalyzes a complicated decarboxylation-deamination process of α-methyl dopa (AMD), leading to the production of 3,4-dihydroxyphenylacetone.
ChEBI: 3,4-Dihydroxyphenylacetone is an alkylbenzene.
